Jahangir Abdi

200 Elizabeth Street, 11E-413
Toronto, ON M5G2C4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.

Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.

Journal: BMC cancer

Published: October 27, 2018

Concise Review: TLR Pathway-miRNA Interplay in Mesenchymal Stromal Cells: Regulatory Roles and Therapeutic Directions.

Concise Review: TLR Pathway-miRNA Interplay in Mesenchymal Stromal Cells: Regulatory Roles and Therapeutic Directions.

Journal: Stem cells (Dayton, Ohio)

Published: June 11, 2018

Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis.

Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis.

Journal: Journal of hematology & oncology

Published: September 25, 2017

Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS.

Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS.

Journal: Leukemia

Published: August 31, 2017

Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.

Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.

Journal: Journal of hematology & oncology

Published: April 12, 2017

Role of micro-RNAs in drug resistance of multiple myeloma.

Role of micro-RNAs in drug resistance of multiple myeloma.

Journal: Oncotarget

Published: May 18, 2016

MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.

MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.

Journal: Oncotarget

Published: September 03, 2015

Erratum: Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.

Erratum: Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.

Journal: Oncotarget

Published: April 30, 2015

PRIMA-1Met induces apoptosis in Waldenström's Macroglobulinemia cells independent of p53.

PRIMA-1Met induces apoptosis in Waldenström's Macroglobulinemia cells independent of p53.

Journal: Cancer biology & therapy

Published: March 25, 2015

miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.

miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 04, 2014

Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells.

Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells.

Journal: The Journal of nutritional biochemistry

Published: April 02, 2014

Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment.

Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment.

Journal: Biomarker research

Published: March 28, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026